Europe Medical Gas and Equipment Market

The Europe medical gas and equipment market is projected to reach USD 8.19 billion by 2031 from USD 6.00 billion in 2025, at a CAGR of 5.3% during the forecast period.

The Europe medical gas and equipment market is booming, driven by structural and temporary factors that are pushing demand higher and accelerating product innovation. The main driver of demand is a growing patient pool resulting from demographic changes and a higher prevalence of chronic respiratory and cardiovascular diseases, all of whom require oxygen supplementation, anesthetic gases, and long-term respiratory support. In parallel, technological and product innovations are making treatments outside hospitals safer, opening new commercial segments. The COVID-19 pandemic, in this regard, acted as a catalyst by spotlighting the indispensability of medical oxygen and prompting many hospitals and national health systems to upgrade infrastructure and stockpile equipment, thereby creating sustained, higher baseline demand and investment. Moreover, policy and reimbursement trends, coupled with the shift toward home healthcare and the growing number of procedures that require perioperative gas systems, are collectively driving market expansion as payers and providers get on board with outpatient and home-based care models. Lastly, supply chain and procurement changes are not only reshaping the supplier landscape but also prompting investment in more reliable, locally supported gas and equipment solutions.

To know about the assumptions considered for the study download the pdf brochure

Some of the prominent players operating in the market include Air Liquide (France), Linde PLC (Germany), Air Products and Chemicals, Inc. (US), Messer SE & Co. KGaA (Germany), Taiyo Nippon Sanso Corporation (Japan), and other players.

Throughout Europe, the leading suppliers of medical gases and related equipment are intensifying their dominance by repeatedly upgrading pipeline systems, manifolds, alarm panels, and on-site oxygen generation technologies, while simultaneously extending their presence in hospitals, clinics, and home-care networks across the region. The major share of R&D expenses is being redirected to digitalized, energy-efficient medical gas pipeline systems that provide real-time monitoring, predictive maintenance alerts, and redundancy features to guarantee an uninterrupted oxygen, air, and vacuum supply in operating rooms, ICUs, and ambulatory surgery centers. To increase their market penetration, major manufacturers are signing strategic partnership agreements with hospital groups, home-care providers, and local distributors to retrofit old infrastructure, comply with the EN ISO 7396-1 and HTM 02-01 standards, and launch modular systems designed for smaller facilities and decentralized care settings. These partnerships typically combine equipment deployment with training programs for biomedical engineers and clinical staff, remote performance analytics, and sustainability initiatives such as cylinder recycling and anesthetic gas capture, which not only accelerate adoption but also enable providers to contribute to the EU Green Deal objectives. Consequently, trust among surgeons and clinicians in sophisticated gas delivery and monitoring solutions continues to grow, leading to rapid acceptance across high-acuity departments and home-healthcare environments, and thus, resilient installed-base ecosystems for the medical gas and equipment market in Europe are emerging.

In April 2025, Air Liquide introduced ECO ORIGIN as an environmentally friendly medical and industrial gas solution complementary to client needs. The offer covers essential gases such as oxygen, nitrogen, argon, and carbon dioxide, produced using pure renewable energy sources and accompanied by an ISO-standardized carbon footprint from production to delivery. Following the initial launch focused on healthcare customers, ECO ORIGIN was then promoted across various industries and has been widely accepted in a very short time. This is evidenced by the signing of agreements with more than 20 hospitals and clinics in six European countries, where the need for sustainable medical gas solutions in Europe is the strongest.

In June 2025, ESAB Corporation (GCE) improved its medical gas equipment portfolio by acquiring Delta P Gas Equipment, an Italian company, and by deciding to acquire Aktiv Technologies in India. These acquisitions enable ESAB to provide more comprehensive medical central gas system solutions, strengthen its global presence, and enhance safety and regulatory compliance in its gas control equipment offering.

In January 2025, Atlas Copco Group acquired Medi-teknique Ltd., a UK-based medical gas service provider specializing in the maintenance, servicing, and installation of medical gas pipeline systems. With this acquisition, Atlas Copco extends its regional coverage in the UK and enhances its aftermarket and installation service capacities in the medical gas equipment market.

Air Liquide (France)

Air Liquide is a major player worldwide in the medical gas and equipment market. It is highly present in Europe through its Healthcare business segment. The company provides a full range of medical gases comprising oxygen, nitrogen, nitrous oxide, medical air, and specialty gases that are used in hospitals, clinics, home care, and emergency care. Moreover, Air Liquide provides a vast range of equipment to go with the gases and also services such as oxygen concentrators, ventilators, anesthesia delivery systems, gas distribution and pipeline solutions, and digital monitoring tools for hospital gas management. The company is especially strong in home healthcare, and, therefore, it is the most suitable partner for Europe in its change to outpatient and home-based care by providing the necessary equipment and services for long-term oxygen therapy, sleep apnea, and chronic respiratory disease management. With an advanced production facility, stable distribution networks, and continuous investments in innovation and sustainability (such as low-carbon oxygen production and digital solutions), Air Liquide has a strong position as a strategic supplier to European healthcare systems and a major contributor to the growth of the medical gas and equipment market.

Linde PLC (Germany)

Linde plc is among the top 3 largest suppliers globally in the medical gas and equipment market, and it has been a great success in Europe through its healthcare business division. The company provides various medical gases. These include medical oxygen, nitrous oxide, medical air, carbon dioxide, and gas mixtures that are used in anesthesia, respiratory therapy, critical care, and diagnostic applications. Along with gases, Linde provides a full line of medical gas equipment and services such as on-site gas supply systems, bulk and cylinder delivery, hospital pipeline installations, flowmeters, pressure regulators, and integrated gas management solutions that ensure safety and regulatory compliance. Linde, furthermore, facilitates home healthcare and long-term oxygen therapy through portable oxygen systems and the rest of the respiratory care equipment. With the help of a wide-ranging production capability, a strong European distribution network, and great expertise in gas engineering and safety standards, Linde is playing an indispensable part in the provision of the medical gas supply that is uninterrupted, and therefore, Linde remains a very important contributor to the growth and modernization of the Europe medical gas and equipment

The Europe medical gases and equipment market is primarily controlled by a few large multinational gas companies that have a strong presence across hospital networks, ambulatory surgery centers, and home-care channels in the region. The top tier is made up of Linde plc and Air Liquide, with their vast European production footprint, pipeline and bulk supply infrastructure, and long-term contracts with major healthcare systems, are positioned as the primary suppliers of medical oxygen, nitrous oxide, and the equipment related to these, such as manifolds, cylinders, and pipeline systems. Not far behind, Messer Group is enhancing its presence, especially in Germany, Italy, and the surrounding countries, where it is deeply engaged in providing customized hospital gas solutions and service-intensive offerings. At the same time, Atlas Copco and GCE Group are widening the competitive landscape with the introduction of specialized vacuum systems, gas control equipment, and monitoring technologies. Taiyo Nippon Sanso, Air Products and Chemicals, and other local players keep the competition alive by focusing on niche applications and partnering with local distributors; however, they are still behind the dominant European incumbents in terms of the depth of their installed base and long-term healthcare relationships.

Related Reports:

Europe Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User [Hospital, Home Healthcare]-Regional Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]